Survey of Incidence of Respiratory Tract Infections

NCT06649032 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1736

Last updated 2025-08-11

No results posted yet for this study

Summary

The purpose of this study is to acquire reliable and current data on the actual incidence (post-COVID) of respiratory tract infections in the general adult population in the absence of any intervention. These data will provide useful background information for designing future studies aimed at assessing whether preventive measures or pharmacological treatments are beneficial in reducing the frequency and severity of infectious episodes.

Conditions

  • Healthy Adults
  • Not Healthy Adults

Interventions

OTHER

No intervention

no difference: both cohorts are followed in the same way

Sponsors & Collaborators

  • Istituto di Farmacologia Traslazionale - National Research Council (IFT-CNR)

    collaborator UNKNOWN
  • Lallemand Pharma AG

    lead INDUSTRY

Principal Investigators

  • Sergio Bonini, Professor · Institute of Translational Pharmacology, Italian National Research Council (IFT-CNR)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-07
Primary Completion
2025-05-31
Completion
2025-07-17

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06649032 on ClinicalTrials.gov